 |
Acorda Therapeutic ACOR (news,
chart,
quote) - ACOR June & July volatility Elevated into data
ACOR, a commercial stage biopharmaceutical company developing treatments to improve neurological functions, is recently at $22.67. ACOR Fampridine-SR (MS treatmen |
|
